Capital expenditure increased 66.2%
Capital expenditure changed +66.2% from the comparable as-filed period.
$60.5M→$100.6M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GRMN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 12.2%
Revenue changed +12.2% from the comparable as-filed period.
$1.8B→$2.0B2 prior comparisons
Gross profit increased 20.2%
Gross profit changed +20.2% from the comparable as-filed period.
$1.0B→$1.3B2 prior comparisons
Free-cash-flow margin moved 924 bp lower
Free-cash-flow margin changed -924 basis points from the comparable as-filed period.
24.00%→14.77%2 prior comparisons
Operating cash flow / net income decreased 39.9%
Operating cash flow / net income changed -39.9% from the comparable as-filed period.
1.21→0.732 prior comparisons
Operating cash-flow margin moved 759 bp lower
Operating cash-flow margin changed -759 basis points from the comparable as-filed period.
27.42%→19.83%2 prior comparisons
Receivables / revenue moved 329 bp higher
Receivables / revenue changed +329 basis points from the comparable as-filed period.
53.96%→57.26%2 prior comparisons
Trade receivables increased 19.0%
Trade receivables changed +19.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$955.6M→$1.1B4 prior comparisons
Capex / revenue moved 165 bp higher
Capex / revenue changed +165 basis points from the comparable as-filed period.
3.42%→5.06%2 prior comparisons
Current assets increased 11.6%
Current assets changed +11.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$5.8B→$6.5B4 prior comparisons
Research & development increased 9.2%
Research & development changed +9.2% from the comparable as-filed period.
$286.5M→$312.9M2 prior comparisons
Working capital increased 7.3%
Working capital changed +7.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$4.1B→$4.4B4 prior comparisons
Working capital / assets moved 226 bp lower
Working capital / assets changed -226 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
38.57%→36.31%4 prior comparisons
Cash & equivalents decreased 1.6%
Cash & equivalents changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$2.1B→$2.0B4 prior comparisons
Selling, general & administrative increased 9.9%
Selling, general & administrative changed +9.9% from the comparable as-filed period.
$303.2M→$333.2M2 prior comparisons
SBC / revenue moved 16 bp lower
SBC / revenue changed -16 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.41%→2.25%2 prior comparisons
Shares outstanding increased 0.2%
Shares outstanding changed +0.2% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
192,334,806→192,695,2988 prior comparisons
Stock-based compensation increased 4.7%
Stock-based compensation changed +4.7% from the comparable as-filed period.
$42.7M→$44.7M2 prior comparisons
R&D / revenue moved 42 bp lower
R&D / revenue changed -42 basis points from the comparable as-filed period.
16.18%→15.76%2 prior comparisons
Cost of revenue increased 0.5%
Cost of revenue changed +0.5% from the comparable as-filed period.
$724.4M→$728.3M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.